SEC Form 4 · accession 0001578259-15-000048

NOVELION THERAPEUTICS INC. · NVLN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jun 7, 2015

Accepted (ET)

Jun 9, 2015 · 9:00 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000827809

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Shares^F1	Jun 7, 2015	M	4,000	—	A	76,000	D
Common Shares^F1	Jun 7, 2015	M	6,000	—	A	82,000	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Unit^F1,F2,F4	—	Jun 7, 2015	M	4,000	D	—	—	Common Shares	4,000	0	D
Restricted Stock Unit^F1,F3,F4	—	Jun 7, 2015	M	6,000	D	—	—	Common Shares	6,000	0	D

F1Restricted stock units convert into common shares on a one-for-one basis upon vesting.
F2On July 15, 2013, the Reporting Person was granted 6,000 restricted stock units, which vest in three successive and equal yearly installments on the date of each of the first three annual general meetings of the Issuer held after July 15, 2013. On June 7, 2015, the Board of Directors of QLT approved the immediate vesting of all restricted stock units held by the Reporting Person.
F3On December 17, 2014, the Reporting Person was granted 6,000 restricted stock units, which vest in three successive and equal yearly installments on the date of each of the first three annual general meetings of the Issuer held after December 17, 2014. On June 7, 2015, the Board of Directors of QLT approved the immediate vesting of all restricted stock units held by the Reporting Person.
F4The restricted stock units have no fixed expiration date, but unvested units expire upon the Reporting Person's termination of service.